Evelo Biosciences Inc To Provide Business Update Transcript
Good morning, and welcome to Evelo Biosciences conference call to discuss its recent business updates. (Operator Instructions) Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request.
At this time, I'd like to turn the call over to Kendra Sweeney of Evelo. Please proceed.
Thank you.
This morning, we issued a press release that outlines the topics we plan to discuss today. This release is available at www.evelobio.com under the Investors tab.
Today on our call, we have Simba Gill, Chief Executive Officer; Duncan McHale, Chief Medical Officer; Marella Thorell, Chief Financial Officer; and Douglas Maslin, EDP1815 Clinical Lead.
Before we begin, I would like to remind everyone that statements made during this call that do not relate to matters of historical facts, including statements about our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
